Ignite Creation Date:
2025-12-24 @ 1:21 PM
Ignite Modification Date:
2026-01-05 @ 1:14 AM
Study NCT ID:
NCT06413095
Status:
COMPLETED
Last Update Posted:
2024-05-14
First Post:
2024-04-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS
Sponsor:
Presage Biosciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-22
Completion Date Type:
ACTUAL
First Submit Date:
2024-04-01
First Submit QC Date:
None
Study First Post Date:
2024-05-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-08
Last Update Post Date:
2024-05-14
Last Update Post Date Type:
ACTUAL